Strasbourg, France, May 22, 2026, 5:45 p.m. CET – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 22, 2026) at 11:00 a.m. CET at the Company’s headquarters (400 boulevard Gonthier d’Andernach – Parc d’Innovation – 67400 Illkirch-Graffenstaden, France).
The Combined General Meeting was chaired by Alessandro Riva, Chairman and Chief Executive Officer. In addition to approving the statutory and consolidated financial statements for the fiscal year ended December 31, 2025, and the “Say on Pay” resolutions, the Combined General Meeting was also called to vote on all resolutions submitted to it, notably regarding the renewal of Directors’ terms of office, financial authorizations, and delegations of authority granted to the Board of Directors to operate on the Company’s share capital.
All resolutions recommended for approval by the Board of Directors were adopted by the shareholders.
.../...
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer